Systemic therapies and primary tumour downsizing in renal cell carcinoma: a real-world comparison of anti-angiogenic and immune checkpoint inhibition regimens

Purpose To investigate responses in the primary tumour to different systemic treatment regimens in patients with metastatic renal cell carcinoma (mRCC). Methods A single-centre retrospective analysis of treatment-naive mRCC patients without prior nephrectomy receiving VEGF tyrosine kinase inhibitors...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of urology 2024-07, Vol.42 (1), p.442, Article 442
Hauptverfasser:	Bickley, Leo Jurascheck, Yang, Yu-Hsuen, Jackson-Spence, Francesca, Toms, Charlotte, Sng, Christopher, Flanders, Lucy, Bex, Axel, Powles, Thomas, Szabados, Bernadett
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Angiogenesis Angiogenesis Inhibitors - therapeutic use Carcinoma, Renal Cell - drug therapy Female Humans Immune checkpoint inhibitors Immune Checkpoint Inhibitors - therapeutic use Kidney cancer Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Male Medicine Medicine & Public Health Metastases Middle Aged Nephrectomy Nephrology Oncology Renal cell carcinoma Retrospective Studies Survival Rate Treatment Outcome Tumors Urology Vascular endothelial growth factor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!